EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes from papillary thyroid carcinoma

Shen Zhang, Yunyun Liu, Bangguo Zhou, Huixiong Xu

Clinical Hemorheology and Microcirculation · 2024

DOI: 10.3233/ch-231998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Hemorheology and Microcirculation, 2024. Verfasst von Shen Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Nanjing Medical University, Sha…. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Lymphatic Metastasis, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes (LNs) from papillary thyroid carcinoma (PTC). MATERIALS AND METHODS: A total of 77 patients with 79 LNs ablated by microwave ablation (MWA) or radiofrequency ablation (RFA) between September 2018 and October 2022 were enrolled in this study. After treatment, patients were followed up with measurement of diameters of LNs and serum thyroglobulin (s-Tg) at 1, 3, 6, and 12 months and annually thereafter. The paired t-test was used to compare the changes of s-Tg level, diameters of LNs before and after ablation. RESULTS: There were no serious complications related to ablation while one case of incomplete ablation in MWA was found during follow-up. The mean longest and shortest diameter of the ablated LNs reduced from 11.6 ± 4.3 mm to 5.0 ± 4.1 mm (p < 0.001), and from 6.1 ± 1.9 mm to 3.0 ± 2.5 mm (p < 0.001) at the last follow-up visit. Besides, the final volume reduction rate (VRR) was 61.8 ± 56.4% (range, –67.0 –100%). The complete disappearance rate was 46.8%, but there were 4 (5.1%) LNs becoming bigger than before. The average s-Tg level was 9.2 ± 26.6 ng/mL, a data significantly decreased to 3.7 ± 7.0 ng/mL at the last follow-up, but no statistical difference was shown. CONCLUSION: Thermal ablation is an effective and safe modality for the treatment of metastatic LNs from PTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryLymphatic MetastasisThyroid NeoplasmsHumansFemaleMaleMiddle AgedAdultLymph NodesRadiofrequency AblationUltrasonography, InterventionalAgedTreatment Outcome

Stichwörter der Autor:innen

Ultrasoundlymph nodespapillary thyroid carcinomathermal ablation

Autor:innen und Institutionen

  • Department of Medical Ultrasound, Center of Minimally Invasive Treatment for Tumor, Shanghai Tenth People's Hospital, Nanjing Medical University, Shanghai, China.
  • Department of Medical Ultrasound, Ultrasound Research and Education Institute, Clinical Research Center for Interventional Medicine, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, Chi…
  • Shanghai Engineering Research Center of Ultrasound Diagnosis and Treatment, Shanghai, China.
  • Department of Ultrasound, Institute of Ultrasound in Medicine and Engineering, Zhongshan Hospital, Fudan University, Shanghai, China.

Zitieren

APA

Zhang, S., Liu, Y., Zhou, B., & Xu, H. (2024). Efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes from papillary thyroid carcinoma. Clinical Hemorheology and Microcirculation. https://doi.org/10.3233/ch-231998

Vancouver

Zhang S, Liu Y, Zhou B, Xu H. Efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes from papillary thyroid carcinoma. Clinical Hemorheology and Microcirculation. 2024. doi:10.3233/ch-231998

BibTeX
@article{Zhang2024,
  author = {Zhang, Shen and Liu, Yunyun and Zhou, Bangguo and Xu, Huixiong},
  title = {Efficacy and safety of percutaneous ultrasound-guided thermal ablation in the treatment of cervical metastatic lymph nodes from papillary thyroid carcinoma},
  journal = {Clinical Hemorheology and Microcirculation},
  year = {2024},
  doi = {10.3233/ch-231998}
}
Kostenlos starten →